HCA Healthcare, Inc. (BVMF:H1CA34)
Brazil · Delayed Price · Currency is BRL | Market Cap | 538.85B -8.4% |
| Revenue (ttm) | 407.66B +5.8% |
| Net Income | 35.10B +6.8% |
| EPS | 8.11 +17.1% |
| Shares Out | n/a |
| PE Ratio | 15.28 |
| Forward PE | 15.66 |
| Dividend | 0.54 (0.44%) |
| Ex-Dividend Date | Sep 15, 2026 |
| Volume | 1,538 |
| Open | 124.55 |
| Previous Close | 121.05 |
| Day's Range | 122.56 - 124.55 |
| 52-Week Range | 91.80 - 143.06 |
| Beta | 1.11 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 27, 2026 |
About HCA Healthcare
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and a... [Read more]
Financial Performance
In 2025, HCA Healthcare's revenue was $75.60 billion, an increase of 7.08% compared to the previous year's $70.60 billion. Earnings were $6.78 billion, an increase of 17.78%.
Financial numbers in USD Financial StatementsNews
More Than 100 HCA Healthcare Hospitals Recognized by Healthgrades for Excellence in Specialty Care
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that 102 of its hospitals have been recognized by Healthgrades for...
HCA Healthcare price target raised to $401 from $387 at Barclays
Barclays analyst Andrew Mok raised the firm’s price target on HCA Healthcare (HCA) to $401 from $387 and keeps an Equal Weight rating on the shares.
HCA Healthcare price target raised to $490 from $435 at KeyBanc
KeyBanc analyst Matthew Gillmor raised the firm’s price target on HCA Healthcare (HCA) to $490 from $435 and keeps an Overweight rating on the shares. The firm says Q3 results…
HCA Healthcare price target raised to $486 from $460 at TD Cowen
TD Cowen raised the firm’s price target on HCA Healthcare (HCA) to $486 from $460 and keeps a Buy rating on the shares. The firm updated its model following better…
HCA Healthcare price target raised to $495 from $475 at Mizuho
Mizuho raised the firm’s price target on HCA Healthcare (HCA) to $495 from $475 and keeps an Outperform rating on the shares.
HCA Healthcare price target raised to $409 from $393 at Baird
Baird raised the firm’s price target on HCA Healthcare (HCA) to $409 from $393 and keeps a Neutral rating on the shares. The firm updated its model with a 2027…
HCA Healthcare price target raised to $500 from $450 at BofA
BofA raised the firm’s price target on HCA Healthcare (HCA) to $500 from $450 and keeps a Neutral rating on the shares. The company’s Q3 EBITDA came in 5% above…
HCA Healthcare sees 2027 earnings ‘generally consistent’ with 2026
Beyond 2027, sees performance more in line with long-term growth targets. Comments taken from Q3 earnings conference call.
HCA Healthcare drop 2.1% to $454.97 after providing guidance on Q3 earnings call
10:13 EDT HCA Healthcare (HCA) drop 2.1% to $454.97 after providing guidance on Q3 earnings call
HCA Healthcare Earnings Call Transcript: Q3 2026
Q3 volume growth, stronger insured revenue per unit and cost control supported results slightly above expectations, despite a $400 million exchange-related Adjusted EBITDA headwind. Preliminary 2027 expectations are 2%-3% volume growth and earnings generally consistent with 2026, with policy and payer mix key uncertainties.
HCA Healthcare Earnings release: Q3 2026
HCA Healthcare released its Q3 2026 earnings on October 27, 2026, summarizing the period's financial results.
HCA Healthcare Profit Slips but Revenue Rises
The operator of healthcare facilities on posted net income of $1.58 billion, compared with $1.64 billion in the same quarter a year ago.
HCA Healthcare reports Q3 adjusted EPS $7.22, consensus $6.63
Reports revenue $19.85B, consensus $19.33B. “I have often mentioned that HCA has strong staying power because of our scale, the important role we play in providing critical services to communities,…
HCA Healthcare sees FY results in ‘upper half’ of 2026 estimated guidance ranges
The Company now believes its full year operating results will be in the upper half of its 2026 estimated guidance ranges previously issued on July 14, 2026. Published first on…
HCA Healthcare Reports Third Quarter 2026 Results
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2026. Key third quarter metrics (all perce...
HCA Healthcare to Host Eighth Annual “Crush the Crisis” National Prescription Drug Take Back Day
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced it will host its eighth annual “Crush the Crisis” national prescri...
HCA Healthcare price target raised to $460 from $431 at TD Cowen
TD Cowen raised the firm’s price target on HCA Healthcare (HCA) to $460 from $431 and keeps a Buy rating on the shares. The firm brings Q3 adjusted EBITDA down,…
HCA Healthcare price target raised to $496 from $435 at RBC Capital
RBC Capital raised the firm’s price target on HCA Healthcare (HCA) to $496 from $435 and keeps an Outperform rating on the shares as part of a broader research note…
HCA Healthcare, Inc. 3rd Quarter 2026 Earnings Conference Call
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q 2026 Earnings Call When: Tuesday, October 27, 2026, at 9:00 AM Centra...
HCA Healthcare Presents 2026 Awards of Distinction
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today presented its annual HCA Healthcare Awards of Distinction at a ceremony in N...
HCA Healthcare started at Outperform at BMO amid strong demographic tailwinds
As previously reported, BMO Capital analyst Sean Dodge initiated coverage of HCA Healthcare (HCA) with an Outperform rating and $495 price target The company’s ongoing investments in attractive geogra...
HCA Healthcare initiated with an Outperform at BMO Capital
BMO Capital initiated coverage of HCA Healthcare (HCA) with an Outperform rating and $495 price target
HCA Healthcare Transcript: 2026 Jefferies Healthcare Services and Technology Conference
The hospital sector is navigating significant policy and payer mix changes, but demand and volume growth remain strong. Financial guidance reflects exchange-related headwinds offset by supplemental payments, while ongoing investments in network expansion, cost management, and digital transformation support long-term growth and resiliency.
HCA Healthcare completes acquisition of CHCP
HCA Healthcare (HCA) announced that it has completed the previously announced acquisition of The College of Health Care Professions, CHCP. The acquisition of CHCP builds on HCA Healthcare’s longstandi...